PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate.
Saved in:
| Title: | PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate. |
|---|---|
| Authors: | Chessa TAM; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK. Electronic address: tamara.chessa@babraham.ac.uk., Jung P; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Anwar A; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Suire S; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Anderson KE; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Barneda D; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Kielkowska A; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Sadiq BA; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Lai IW; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Felisbino S; Department of Structural and Functional Biology, São Paulo State University, Botucatu, SP CEP: 18618-689, Brazil., Turnham DJ; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK., Pearson HB; European Cancer Stem Cell Research Institute, Cardiff University, Cardiff CF24 4HQ, UK., Phillips WA; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Sasaki J; Department of Biochemical Pathophysiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan., Sasaki T; Department of Biochemical Pathophysiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan., Oxley D; Mass Spectrometry Facility, Babraham Institute, Cambridge CB22 3AT, UK., Spensberger D; Gene Targeting Facility, Babraham Institute, Cambridge CB22 3AT, UK., Segonds-Pichon A; Bioinformatics, Babraham Institute, Cambridge CB22 3AT, UK., Wilson M; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Walker S; Imaging Facility, Babraham Institute, Cambridge CB22 3AT, UK., Okkenhaug H; Imaging Facility, Babraham Institute, Cambridge CB22 3AT, UK., Cosulich S; Projects Group, Oncology R&D, AstraZeneca, Cambridge, UK., Hawkins PT; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK., Stephens LR; Signalling Programme, Babraham Institute, Cambridge CB22 3AT, UK. Electronic address: len.stephens@babraham.ac.uk. |
| Source: | Molecular cell [Mol Cell] 2023 Aug 17; Vol. 83 (16), pp. 2991-3009.e13. Date of Electronic Publication: 2023 Aug 10. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 9802571 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4164 (Electronic) Linking ISSN: 10972765 NLM ISO Abbreviation: Mol Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
